Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
99.38
+2.05 (2.11%)
May 28, 2026, 12:59 PM EDT - Market open
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Mirum Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $144.15. The average 1-year stock price forecast is 45.05% higher than the current stock price, while the lowest is $115 (+15.72%) and the highest is $185 (+86.15%).
Price Target: $144.15 (+45.05%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mirum Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 9 |
| Buy | 2 | 2 | 3 | 3 | 3 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 11 | 11 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $185 | Buy | Reiterates | $185 | +86.15% | May 22, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Initiates $115 | Buy | Initiates | $115 | +15.72% | May 20, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $145 | Buy | Initiates | $145 | +45.90% | May 19, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $150 → $154 | Buy | Maintains | $150 → $154 | +54.96% | May 15, 2026 |
| Raymond James | Raymond James | Buy Maintains $164 → $165 | Buy | Maintains | $164 → $165 | +66.03% | May 7, 2026 |
Financial Forecast
Revenue This Year
685.17M
from 521.31M
Increased by 31.43%
Revenue Next Year
824.34M
from 685.17M
Increased by 20.31%
EPS This Year
-11.31
from -0.47
EPS Next Year
-0.52
from -11.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 716.4M | 941.4M | ||||||
| Avg | 685.2M | 824.3M | ||||||
| Low | 627.5M | 698.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 37.4% | 37.4% | ||||||
| Avg | 31.4% | 20.3% | ||||||
| Low | 20.4% | 1.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.84 | 0.33 | ||||||
| Avg | -11.31 | -0.52 | ||||||
| Low | -15.48 | -1.30 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.